feed,title,long_url,short_url
Benzinga,Glaukos' iLink Therapy Meets Primary Endpoint In Late-Stage Vision Disorder Study,https://benzinga.com/general/biotech/21/02/19877541/glaukos-ilink-therapy-meets-primary-endpoint-in-late-stage-vision-disorder-study,
